Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival

References

• DeoliveiraMLCunninghamSCCameronJLCholangiocarcinoma: thirty-one-year experience with 564 patients at a single institutionAnn Surg2007245575576217457168
   PubMed Web of Science ®Google Scholar
• CharbelHAl-KawasFHCholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosisCurr Gastroenterol Rep201113218218721271364
   PubMedGoogle Scholar
• DohertyBNambudiriVEPalmerWCUpdate on the diagnosis and treatment of cholangiocarcinomaCurr Gastroenterol Rep2017191228110453
   PubMedGoogle Scholar
• CunninghamSCChotiMABellavanceECPawlikTMPalliation of hepatic tumorsSurg Oncol200716427729117935975
   PubMed Web of Science ®Google Scholar
• CheriyathVLeamanDWBordenECEmerging roles of FAM14 family members (G1P3/ISG 6–16 and ISG12/IFI27) in innate immunity and cancerJ Interferon Cytokine Res201131117318120939681
   PubMed Web of Science ®Google Scholar
• RasmussenUBWolfCMatteiMGIdentification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinomaCancer Res19935317409641018358738
   PubMed Web of Science ®Google Scholar
• SuomelaSCaoLBowcockASaarialho-KereUInterferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancersJ Invest Dermatol2004122371772115086558
   PubMed Web of Science ®Google Scholar
• KuoYYJimWTSuLCCaffeic acid phenethyl ester is a potential therapeutic agent for oral cancerInt J Mol Sci2015165107481076625984601
   PubMed Web of Science ®Google Scholar
• AlbiniATosettiFLiVWNoonanDMLiWWCancer prevention by targeting angiogenesisNat Rev Clin Oncol20129949850922850752
   PubMed Web of Science ®Google Scholar
• MariottoABYabroffKRShaoYFeuerEJBrownMLProjections of the cost of cancer care in the United States: 2010–2020J Natl Cancer Inst2011103211712821228314
   PubMed Web of Science ®Google Scholar
• RibattiDTumor refractoriness to anti-VEGF therapyOncotarget2016729466684667727081695
   PubMedGoogle Scholar
• YoshikawaDOjimaHIwasakiMClinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinomaBr J Cancer200898241842518087285
   PubMed Web of Science ®Google Scholar
• PengHZhangQLiJApatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinomaOncotarget2016713172201722926967384
   PubMedGoogle Scholar
• TsaiMYYangRCWuHTPangJHHuangSTAnti-angiogenic effect of tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cellsCancer Lett2011310219820621788102
   PubMed Web of Science ®Google Scholar
• ChiangKCYehCNChenHY19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cellsSteroids201176131513151921888924
   PubMed Web of Science ®Google Scholar
• OuyangWMaQLiJCyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytesCancer Res200565209287929316230390
   PubMed Web of Science ®Google Scholar
• TsuiKHChungLCFengTHChangPLJuangHHUpregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cellsInt J Cancer2012130122812282321780100
   PubMed Web of Science ®Google Scholar
• ChiangKCChenSCYehCNMART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitroJ Steroid Biochem Mol Biol2014139546024125734
   PubMed Web of Science ®Google Scholar
• ChiangKCKuoSFChenCHMART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potentialCancer Lett20153691768526282787
   PubMed Web of Science ®Google Scholar
• HsiehWLHuangYHWangTMMingYCTsaiCNPangJHIFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytesCell Prolif201548218719725664647
   PubMed Web of Science ®Google Scholar
• VermeulenKVan BockstaeleDRBernemanZNThe cell cycle: a review of regulation, deregulation and therapeutic targets in cancerCell Prolif200336313114912814430
   PubMed Web of Science ®Google Scholar
• GuptaGPMassaguéJCancer metastasis: building a frameworkCell2006127467969517110329
   PubMed Web of Science ®Google Scholar
• GuarinoMRubinoBBallabioGThe role of epithelial-mesenchymal transition in cancer pathologyPathology200739330531817558857
   PubMed Web of Science ®Google Scholar
• PalenaCFernandoRIHamiltonDHAn immunotherapeutic intervention against tumor progression: targeting a driver of the epithelial-to-mesenchymal transitionOncoimmunology201431e2722024575384
   PubMed Web of Science ®Google Scholar
• WheelockMJShintaniYMaedaMFukumotoYJohnsonKRCadherin switchingJ Cell Sci2008121672773518322269
   PubMed Web of Science ®Google Scholar
• ChristiansenJJRajasekaranAKReassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasisCancer Res200666178319832616951136
   PubMed Web of Science ®Google Scholar
• StrickerJFalzoneTGardelMLMechanics of the F-actin cytoskeletonJ Biomech201043191419913792
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med197128521118211864938153
   PubMed Web of Science ®Google Scholar
• EbosJMKerbelRSAntiangiogenic therapy: impact on invasion, disease progression, and metastasisNat Rev Clin Oncol20118421022121364524
   PubMed Web of Science ®Google Scholar
• JaysonGCHicklinDJEllisLMAntiangiogenic therapy--evolving view based on clinical trial resultsNat Rev Clin Oncol20129529730322330688
   PubMed Web of Science ®Google Scholar
• TischerEMitchellRHartmanTThe human gene for vascular endothelial growth factor. multiple protein forms are encoded through alternative exon splicingJ Biol Chem19912661811947119541711045
   PubMed Web of Science ®Google Scholar
• TsuiKHLinYHChungLCProstate-derived Ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cellsCancer Lett2016375114215126965996
   PubMed Web of Science ®Google Scholar